Large granular lymphocyte leukaemia

Large granular lymphocyte leukaemia is a rare, usually slow-growing blood cancer involving abnormal overgrowth of a specific type of white blood cell (large granular lymphocytes). It often has a chronic, indolent course rather than behaving like an acute leukaemia.

The exact cause isn't fully understood, but it's thought to arise from abnormal, persistent activation of certain immune cells, sometimes associated with autoimmune conditions like rheumatoid arthritis. It's not typically linked to a specific environmental exposure.

Many people have no symptoms and are diagnosed incidentally on routine blood tests, while others experience recurrent infections due to low white cell counts, fatigue from anaemia, or an enlarged spleen. Symptoms tend to develop gradually given the typically slow-growing nature of this condition.

Many cases are indolent and can be monitored for years without needing treatment, though some cases cause troublesome low blood counts requiring active management. Regular haematology follow-up helps ensure timely treatment if the disease becomes more active.

It's not considered a hereditary condition; it develops from an acquired abnormality in immune cell regulation rather than an inherited genetic mutation. It's not passed on to children.

It's generally considered a chronic condition rather than one that's definitively cured, but treatment can effectively control symptoms and blood count problems for extended periods when needed. Many people never need active treatment at all if the disease remains stable and asymptomatic.

Treatment is only started when there are troublesome symptoms or significantly low blood counts, typically using immunosuppressive medications to reduce the abnormal cell population. Watchful waiting with regular monitoring is appropriate for asymptomatic, stable disease.

Monitoring involves regular blood tests to track blood cell counts and the level of abnormal lymphocytes, along with clinical assessment for any new symptoms or infections. Your haematologist will determine the appropriate frequency based on how active the disease is.

Large granular lymphocyte leukaemia specifically involves a distinct cell type with characteristic granules and often a different clinical pattern, including a stronger association with autoimmune conditions and low neutrophil counts, compared to other chronic lymphocytic leukaemias. Specialised blood tests distinguish between these related conditions.

Unexplained recurrent infections, fatigue or abnormal blood counts found on testing should prompt haematology referral. Private haematology consultations can typically be arranged within about two weeks, considerably faster than standard NHS waiting times.